Streetbeat News

Analyst Ratings

DXCM

UBS analyst Danielle Antalffy maintains a Buy rating on DexCom (NASDAQ:DXCM) but lowers the price target from $175 to $138.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:54 pm

ZS

UBS analyst Roger Boyd maintains a Buy rating on Zscaler (NASDAQ:ZS) and raises the price target from $175 to $190.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:53 pm

AAPL

Apple Inc. (NASDAQ:AAPL) faces challenges from Huawei's resurgence in China, a Chinese smartwatch brand Imoo outpacing Apple Watch, Android users accessing iMessage, and leaked features of the upcoming iPhone 15 Pro. Huawei's new smartphones could dent Apple's fiscal 2024 earnings by approximately 11 cents per share if it regains 10 million units of market share. Imoo has captured 21% of the smartwatch market in China, trailing only behind Huawei. Tech influencer Marques Brownlee revealed two methods for Android users to access iMessage, challenging Apple's exclusivity.

Portfolio Pulse from Mohit Manghnani

September 06, 2023 | 1:53 pm

VINP

UBS analyst Mariana Taddeo maintains a Buy rating on Vinci Partners Inv (NASDAQ:VINP) and raises the price target from $13 to $14.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:52 pm

GTLB

UBS analyst Karl Keirstead maintains a 'Buy' rating on GitLab (NASDAQ:GTLB) and raises the price target from $55 to $62.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:51 pm

ENPH

Morgan Stanley analyst Andrew Percoco has maintained an Equal-Weight rating on Enphase Energy (NASDAQ:ENPH) but lowered the price target from $234 to $159.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:50 pm

SPY

The S&P Global Composite PMI for August was reported at 50.2, slightly below the estimated 50.4 and significantly lower than the prior figure of 52.0.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 1:50 pm

ADBE

UBS analyst Karl Keirstead maintains a Neutral rating on Adobe (NASDAQ:ADBE) and raises the price target from $525 to $600.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:48 pm

ASND

Morgan Stanley analyst Vikram Purohit maintains an Equal-Weight rating on Ascendis Pharma (NASDAQ:ASND) and raises the price target from $109 to $113.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 1:46 pm

AAPL

ACI

AMZN

GM

GOOG

KR

MRNA

ROKU

SFTBF

SPOT

TM

UAL

WMG

The Chinese government has banned its officials from using Apple's iPhones and other foreign-branded devices at work. The FTC could prosecute Amazon over antitrust claims. Toyota launched a new version of its chauffeur-driven Century model. SoftBank backed Arm Holdings has launched its roadshow for its IPO. Warner Music has acquired a majority stake in 10K Projects. Roku disclosed measures to cut down its operating expense growth rate. United Airlines flights are back in the air after a temporary grounding. Moderna's updated COVID-19 vaccine is pending FDA approval. Spotify is exploring a move to put lyrics behind its paywall. Google tentatively settled a class action suit for allegedly violating antitrust norms. General Motors said that the UAW union's demands will pressure its manufacturing momentum. C&S Wholesale Grocers, backed by SoftBank, is reportedly approaching a deal to buy stores from Kroger and Albertsons. Apple inked a fresh deal with Arm Ltd for chip technology.

Portfolio Pulse from Vandana Singh

September 06, 2023 | 1:43 pm